Skip to content
DataLookout
Menu

NCT07915895

Retroperitoneal Tumor Registry

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Overall Survival
Timeframe: Up to 5 years after enrollment

Sites

1 site in 1 country

  • The First Hospital of Jilin UniversityChangchun, Jilin, China